Sandoz, a generics and biosimilar unit of Novartis, will make its generic epinephrine shots immediately available for sale in U.S. retail pharmacies as a shortage of Mylan’s lifesaving allergy ...
Consumers are the only ones struggling to pay the rising prices of popular GLP-1 drugs, as states like Connecticut see skyrocketing costs. After spending a combined $103 million in fiscal year 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback